| Views | |
|---|---|
| Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia | 21 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia | 0 | 0 | 0 | 0 | 17 | 2 | 2 |
| Views | |
|---|---|
| 2023_v.Stackelberg_etal.pdf | 12 |
